By constructing both in vivo and in vitro models of NAFLD, researchers observed that m6A modification as well as METTL3 and YTHDF1 expression were significantly elevated in steatosis hepatocytes. The gene discussed is METTL3; the disease is metabolic dysfunction-associated steatotic liver disease.